| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 58 |
| 1 | METFORMIN ER 500 MG | 46 |
| 2 | METFORMIN ER 750 MG | 46 |
| 3 | ALLOPURINOL | 22 |
| 4 | FUROSEMIDE | 22 |
| 5 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 21 |
| 6 | GLIMEPIRIDE | 20 |
| 7 | METFORMIN HYDROCHLORIDE | 12 |
| 8 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 12 |
| 9 | METFORMIN HYDROCHLORIDE TABLET | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE | 1 | 0.0021 |
| 1 | TAGRAXOFUSP | 1 | 0.0019 |
| 2 | NICARDIPINE | 8 | 0.0018 |
| 3 | NICARDIPINE HYDROCHLORIDE | 4 | 0.0018 |
| 4 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 21 | 0.0010 |
| 5 | RASAGILINE MESYLATE | 10 | 0.0009 |
| 6 | PENTOXIFYLLINE | 3 | 0.0007 |
| 7 | EPLERENONE | 9 | 0.0007 |
| 8 | SOLIFENACIN SUCCIATE | 1 | 0.0005 |
| 9 | GLIMEPIRIDE | 20 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Xanthine Oxidase Inhibitor [EPC] | 23 |
| 1 | Loop Diuretic [EPC] | 22 |
| 2 | Sulfonylurea [EPC] | 22 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 14 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 14 |
| 5 | Proton Pump Inhibitor [EPC] | 13 |
| 6 | Benzodiazepine [EPC] | 12 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 8 | Aldosterone Antagonist [EPC] | 10 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 2 | Leukotriene Receptor Antagonist [EPC] | 10 | 0.0003 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Sulfonylurea [EPC] | 22 | 0.0002 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 23 | 0.0001 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 10 | 0.0001 |
| 8 | Cardiac Glycoside [EPC] | 5 | 0.0001 |
| 9 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |